(Q33974706)

30 July 2017

Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys (English)

1 reference

30 July 2017

Orthoebolavirus zairense

0 references

1

Thomas W Geisbert

1 reference

30 July 2017

3

Peter B Jahrling

1 reference

30 July 2017

2

Lisa E Hensley

1 reference

30 July 2017

5

Joan B Geisbert

1 reference

30 July 2017

Tom Larsen

4

1 reference

30 July 2017

Jason Paragas

6

1 reference

30 July 2017

Howard A Young

7

1 reference

30 July 2017

Terry M Fredeking

8

1 reference

30 July 2017

William E Rote

9

1 reference

30 July 2017

George P Vlasuk

10

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 December 2003

1 reference

30 July 2017

1 reference

30 July 2017

362

1 reference

30 July 2017

9400

1 reference

30 July 2017

1953-1958

1 reference

Evaluation in nonhuman primates of vaccines against Ebola virus

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915012-X

7 January 2021

Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915012-X

7 January 2021

Antiviral drug therapy of filovirus infections: S-adenosylhomocysteine hydrolase inhibitors inhibit Ebola virus in vitro and in a lethal mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915012-X

7 January 2021

Treatment of lethal Ebola virus infection in mice with a single dose of an S-adenosyl-L-homocysteine hydrolase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915012-X

7 January 2021

Haematological, biochemical and coagulation changes in mice, guinea-pigs and monkeys infected with a mouse-adapted variant of Ebola Zaire virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915012-X

7 January 2021

Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915012-X

7 January 2021

Tissue factor pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915012-X

7 January 2021

Detection of mononuclear cells as the source of the increased tissue factor mRNA in the liver from lipopolysaccharide-treated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915012-X

7 January 2021

Inhibition of factor VIIa/tissue factor with nematode anticoagulant protein c2: from unique mechanism to a promising new clinical anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915012-X

7 January 2021

Dose-response study of recombinant factor VIIa/tissue factor inhibitor recombinant nematode anticoagulant protein c2 in prevention of postoperative venous thromboembolism in patients undergoing total knee replacement.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915012-X

7 January 2021

Recombinant nematode anticoagulant protein c2, an inhibitor of the tissue factor/factor VIIa complex, in patients undergoing elective coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915012-X

7 January 2021

Disseminated intravascular coagulation: pathophysiological mechanisms and manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915012-X

7 January 2021

Tissue factor pathway inhibitor (TFPI) in disseminated intravascular coagulation: low levels of the activated factor X-TFPI complex

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915012-X

7 January 2021

Fibrin degradation product D-dimer induces the synthesis and release of biologically active IL-1 beta, IL-6 and plasminogen activator inhibitors from monocytes in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915012-X

7 January 2021

10.1016/S0140-6736(03)15012-X

Identifiers

DOI

1 reference

30 July 2017

1 reference